Nuevo método cuantitativo para determinar la proteina P53 en carcinomas vesicales

Archivos Espanoles de Urologia

Volumn 50, Issue 4, 1997, Pages 347-353

  Sierra, Jesús Moreno ^a   De Las Casas, Ma Luisa Maestro ^a   Heredia, Ma Dolores Ortega ^a   Almarza, Javier Chicharro ^a   Jiménez, Enrique Blanco ^a   Moyano, Ángel Silmi ^a   Estévez, Luis Resel ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; ISOLUMINOL; LUMINOL; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR PROTEIN;

ARTICLE; BLADDER TUMOR; CANCER INVASION; CELL DIFFERENTIATION; CHEMISTRY; CHEMOLUMINESCENCE; COMPARATIVE STUDY; CYTOSOL; ENZYME IMMUNOASSAY; EVALUATION; FEMALE; HUMAN; IMMUNOLOGY; MALE; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UROTHELIUM;

ANTIBODIES, MONOCLONAL; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; CHEMILUMINESCENT MEASUREMENTS; CYTOSOL; EVALUATION STUDIES; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; LUMINOL; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0043124094     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. GANNON, J.; LANE, D.: "Protein synthesis required to nuclear a mutant p53 protein which is temperature sensitive for nuclear transport." Nature, 349: 802, 1991.
2. LANE, D.; CRAWFORD, L.: "T antigen is bound to host protein in SV40 transformed cell." Nature, 278: 261, 1979.
3. WRIGHT, C.; MELLON, K. J.; JOHNSTON, P. y cols.: "Expression of mutant p53, c-erb-B2 and epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder." Br. J. Cancer, 63: 967, 1991.
4. REICH, N.; LEVINE, A.: "Growth regulation of a cellular tumour antigen, p53, in non transformed cells." Nature, 308: 199, 1984.
5. FINLAY, C.; HINDS, P.; LEVINE, A.: "P53 proto-oncogene can act as a suppressor of transformation." Cell, 57: 1.083, 1989.
6. VOGELSTEIN, B.; KINZLER, K.: "P53 function and dysfunction." Cell, 70: 523, 1992.
7. SLOAN, A.; PRICE, J.; WEINGERG, R.: "The genetic origins of human cancer." Cancer, 61: 1.963, 1988.
8. JENKINS, J.; RUDGE, K.; CURRIE, G.: "Cellular immortalization by acDNA clone encoding the transformation associated phosphoprotein p53." Nature, 313: 651, 1984.
9. BENCHIMOL, S.: "Immortalization of rat embryon fibroblast by the celullar p53 oncogene." Oncogene, 2: 445, 1988.
10. NIGRO, J.; BAKER, S.; PREINGER, A. y cols.: "Mutation in the p53 gene occur in diverse human tumour types." Nature, 342: 705, 1989.
11. VOGELSTEIN, B.: "Cancer: a deadly inheritance." Nature, 348: 681, 1990.
12. GANON, J.; LANE, D.: "P53 and DNA polymerase a complete for binding to SV40 T antigen." Nature, 329: 456, 1989.
13. FOSSA, S.; BERNER, A.; JACOBSEN, A. y cols.: "Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erb-B2 protein in operable muscle-invasive bladder cancer." Br. J. Cancer, 68: 572, 1993.
14. WOLF, D.; HARRIS, N.; ROTTER, V.: "Reconstitution of p53 expression in a non producer Ab-MuLV transformed cell line by transfection of a functional p53 gene." Cell, 38: 119, 1984.
15. BORLAND, R.; BRENDLER, C.; ISAACS, W.: "Molecular biology of bladder cancer." Hematol. Oncol. Clin. North Am., 6: 31, 1992.
16. MERINO, C.: "Caracterización biológica del carcinoma vesical: expresion de p53, EGFR y oncogen retrovirico erbB-2/neu." Tesis doctoral. Universidad Complkutense. Madrid, 1995.
17. FUJIMOTO, K.; YAMADA, Y.; OKAJIMA, E. y cols.: "Frequent association of p53 gene mutation in invasive bladder cancer." Cancer Res., 52: 1.393, 1992.
18. HOLLESTEIN, M.; SIDRANSKY, D.; VOGELSTEIN, B. y cols.: "P53 mutation in human cancers." Science, 253: 49, 1991.
19. NIGRO, J.; BLAKER, S.; PRESINGER, A.: "Mutations in the p53 gene occur in diverse tumor types." Nature, 324: 705, 1989.
20. TAKAHASHI, R.; HASHIMOTO, T.; XU, H.: "The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma." Cells. Proc. Nat. Acad. Sci. USA, 88: 5.257, 1991.
21. CATTORETT, G.; RILKE, F.; ANDREOLA, S. y cols.: "P53 expression in breast cancer." Int. J. Cancer, 41: 178, 1988.
22. VAN DEN BERG, F.; TIGGES, A.; SCHIPPER, M. y cols.: Br. J. Cancer, 157: 193, 1989.
23. DEITOS, A.: "P53 protein expression in non neoplastic of soft tissue." Histopathology, 1: 45, 1993.
24. SIDRANSKY, D.; ESCHENBACH, A.; TSAI, Y. y cols.: "Identification of p53 gene mutation in bladder cancers and urine samples." Science, 252: 706, 1991.
25. WEE, A.; TEHJRAIJU, G.: "Clinical importance of p53 protein in bladder carcinoma-its precursor lesions." J. Clin. Pathol., 47: 453, 1994.
26. YE, D.; ZHENG, J.; QIIAN, S. y cols.: "Expression of p53 product in Chinese human bladder carcinoma." Urol. Res., 21: 223, 1993.
27. SARKIS, A.; DALBAGNI, G.; CORDON, C.: "Nuclear overexpression of p53 protein in transitional cell bladder cancer: a marker for disease progression." J. Nat. Cancer Inst., 85: 53, 1993.
28. KUCZYK, M.; SERTH, J.; HERVATIN, C. y cols.: "Detection of p53 tumor-suppressor gene protein in bladder tumors and prostate cancer: possible clinical implications." W. J. Urol., 12: 345, 1994.
29. SARKIS, A.; DALBAGNI, G.; CORDON, C. y cols.: "Association of p53 gene nuclear overexpression and tumor progression in carcinoma in situ of the bladder." J. Urol., 152: 388, 1994.
30. KAMMEL, D.; SOIMI, Y.; NUORVA, K. y cols.: "P53 and c-erbB2 expression in schistosomal urinary bladder carcinoma and schistosomal cystitis with premalignant lesions." Virchows Arch., 424: 349, 1994.
31. YOSHIMURA, I.; KUDOH, J.; SAITO, S. y cols.: "P53 gene mutation in recurrent superficial bladder cancer." J. Urol., 153: 1.711, 1995.